China Merchants Health logo

China Merchants Health

Asia, Hunan, China, Nanshan

Description

China Merchants Health is a comprehensive enterprise with a diverse range of businesses.

Investor Profile

China Merchants Health has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 3 rounds, about 100% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Life Science.

Stage Focus

  • Series B (67%)
  • Series C (33%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Life Science
  • Medical Device
  • Genetics
  • Manufacturing
  • Therapeutics
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does China Merchants Health frequently co-invest with?

China Merchants Group
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Cowin Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Gortune Investment
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
Fosun Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CS Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
China Merchants Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
BlackRock
North America, New York, United States, New York
Co-Investments: 1
Porton Pharma Solutions
Asia, Heilongjiang, China, Chongqing
Co-Investments: 1
HM Capital
North America, Texas, United States, Dallas
Co-Investments: 1
China Merchants Venture Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1

What are some of recent deals done by China Merchants Health?

Porton Advanced Solutions

Suzhou, Jiangsu, China

Porton Advanced Solutions provide end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.

BiotechnologyGeneticsManufacturingPharmaceuticalTherapeutics
Series BAug 21, 2022
Amount Raised: $80,000,000
Wellgrow Technology

Shenzhen, Guangdong, China

Wellgrow Technology is a developer of in vitro diagnostic medical equipment and reagents.

BiotechnologyLife ScienceMedical Device
Series BJan 25, 2022
Stemirna

Beijing, Beijing, China

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

BiotechnologyMedicalPharmaceutical
Series CJun 3, 2021
Amount Raised: $187,388,738